Camurus to present at SEB Biotech Seminar in Stockholm
Lund, Sweden — 18 January 2019 — Camurus (NASDAQ STO: CAMX) today announced that that the Company will present at the SEB Biotech Seminar in Stockholm 24 January at 8:30 am. Fredrik Tiberg, President and CEO, will give an update on the company's activities, including the ongoing launch of Buvidal® weekly and monthly depots for the treatment of opioid dependence. About CamurusCamurus is a Swedish science-led biopharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products